admin

With a good deal of pent-up travel demand, keep an eye on experience stocks. For one, according to SWNSDigital.com, 80% of Americans say they need a vacation in 2023 “more than ever before.” Two, according to Hospitalitynet.org, “The most recent American Travel Sentiment Study indicates that 92% of Americans have travel plans in the next six
[embedded content] So, if we’re shorting Tesla (TSLA), should we be buying Rivian (RIVN) and Lucid (LCID) right now? Well, if you’ve been with us for a while, you know our answer is yes. We’re confident that these two companies will win significant market share as their production ramps and that the EV stocks will
As technological innovation continues to integrate into everyday functionalities, investors ought to consider the hottest augmented reality stocks to own for 2023 and beyond. To get everyone on the same page, AR refers to platforms that overlay “visual, auditory, or other sensory information onto the real world to enhance one’s experience,” per Investopedia. It’s another
Amid the latest groundbreaking news in the broader energy space, investors may want to target certain long-term stocks to buy on the nuclear fusion announcement. According to The New York Times, scientists at the Lawrence Livermore National Laboratory in California announced a major milestone: they laid the groundwork in reproducing the power of the sun
Although a new year tends to bring feelings of optimism, when it comes to the current market dynamics, it’s time to consider hot stocks to book profits in before 2023 arrives. At first, circumstances appeared favorable, with CNN reporting on Dec. 13 that inflation cooled more than expected. However, by the following day, the Federal
In this article AJRD TSLA MESA SBGI Follow your favorite stocksCREATE FREE ACCOUNT Check out the companies making headlines before the bell: Aerojet Rocketdyne (AJRD) – Aerojet Rocketdyne agreed to be bought by rival defense contractor L3Harris Technologies (LHX) for $4.7 billion, or $58 per share in cash. Aerojet Rocketdyne rose 2% in the premarket,
Some of the hottest biotech stocks are safe and recession-proof. After all, we can’t stop people from aging – at least, not yet. We can’t stop people from seeking treatments for a myriad of issues. Plus, there’s growing demand for innovation in gene therapies, immune-oncology, precision medicine, machine-learning drug discovery, and treatments for unmet medical
Major indices such as the S&P 500 and the Nasdaq Composite may have plunged by double-digits during 2022, but certain areas of the stock market performed strongly throughout the year. One of those areas is among the hottest healthcare stocks. With company-specific catalysts outweighing negative macro factors such as high inflation, rising interest rates, and slowing economic growth, scores